Reducing residual cardiovascular risk Reducing residual cardiovascular risk in patients treated with statins and having hypertriglyceridemia was addressed by Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT)
GI bleed with Continuous flow LVAD – Mechanisms Gastrointestinal bleeds can occur in 15-40% of patients on continuous flow left ventricular assist devices (LVAD) for end stage heart
Better postoperative outcome with Class II indications for surgery in Aortic Regurgitation? Are Class II indications for surgery in hemodynamically significant chronic aortic regurgitation better than Class I
High-quality plant protein sources – legumes, soy, nuts – improve lipid profile Meta-analysis published in Circulation [1] evaluated randomized controlled trials comparing red meat consumption with other diets regarding cardiovascular
Out of Hospital Cardiac Arrest third leading cause of DALY Disability Adjusted Life Years (DALY) following adult nontraumatic Out of Hospital Cardiac Arrest (OHCA) treated by Emergency Medical
Visualization of stent during coronary angioplasty Blue arrows: edges of stent; red arrows: balloon edge markers (there will be an overhang of the balloon beyond the markers on
United States Food and Drug Administration (US FDA) has approved SuperSaturated Oxygen (SSO2) Therapy for reducing infarct size in left anterior descending coronary artery territory ST elevation myocardial
Percutaneous Mitral Valve Repair Mitral regurgitation is the commonest valvular lesion, due to aging of the population at large and degenerative valvular heart disease overtaking rheumatic heart disease.